Table 1.
Radiological and clinical data
| Female/male | 25/40 |
| Age (mean ± SD), years TOAST | 67±14 |
| TOAST | |
| Atherothrombotic | 14/65 (21.5) |
| Cardioembolic | 36/65 (55.4) |
| Undetermined | 10/65 (15.6) |
| Other determined (dissections) | 5/65 (7.5) |
| Median NIHSS score at entry | 16 (10–20) |
| Time to CT (mean ± SD), min | 219±43 |
| Unknown time of onset (wake-up stroke) | 8/65 (12) |
| Median CT_ASPECTS on admission | 9 (8–10) |
| Median CBV_ASPECTS on admission | 8 (8–10) |
| Occlusion location on CTA at admission, n/total | |
| MCA-M1 | 30/65 (4.2) |
| MCA-M2 | 13/65 (20) |
| Proximal ICA | 6/65 (9.2) |
| IV rtPA, n/total | 35/65 (53.8) |
| Time to groin (mean ± SD), min | 304±178 |
| Time to recanalization or end procedure, mean ± SD, min Final TICI score, n/total | 347±148 |
| 0–1 | 5/65 (7.5) |
| 2a | 9 (13.4) |
| 2b | 26 (38) |
| 3 | 25 (37.3) |
| Median NIHSS score at 24 h | 9 (3–18) |
| Final infarct volume on CT at 24 h (mean ± SD), ml | 31.6±48.9 |
| Symptomatic intracranial hemorrhage, n/total | 3/65 (1.95) |
| 3-month mRS score <3, n/total | 30/65 (46.1) |
Figures in parentheses are percentages or IQR, unless indicated otherwise. TOAST = Trial of ORG 10172 in acute stroke treatment; IV rtPA = intravenous recombinant tissue plasminogen activator.